Liver Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Apr 15, 2003; 9(4): 678-682
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.678
Figure 1
Figure 1 PCR amplified products of HCA587. (Lanes 1: 1 kb DNA marker; lane 2: 1.2 kb fragment of HCA587; lane 3: nega-tive control).
Figure 2
Figure 2 Recombinant pFasBac Htb-587 vector digested by BamH I and Hind III. (Lanes 1: 1 kb DNA marker; lane 2: recom-binant plasmid; lane 3: digested by BamH I; lane 4: digested by BamH I + Hind III).
Figure 3
Figure 3 PCR identification of recombinant Bacmid-587. (lane 1: DNA marker; lane 2-3: recombinant Bacmid-587; lane 4-5: blank bacmid).
Figure 4
Figure 4 Western blot analysis of recombinant protein ex-pression in sf9 insect cells after transfection. (lane 1: positive control; lane 2: Sf9 cell transfected with bacmid-587; lane 3: blank Sf9 cells).
Figure 5
Figure 5 SDS-PAGE analysis of recombinant HCA587. (lane 1: protein marker; lane 2: sf9 lysate; lane 3: infected sf9 lysate; lane 4-5: purified HCA587 protein).
Figure 6
Figure 6 Western blot of recombinant HCA587 reacting with positive serum. (lane 1: protein marker; lane 2: positive serum of HCC; lane 3: negative control).
Figure 7
Figure 7 Serological analysis of HCC patients with recombi-nant protein HCA587. (lane 2 and 11: positive; others: negative; left: protein marker).